Skyrocketing Costs of Common Diabetes Medications Limit Access to Effective Treatments for Low-Income Individuals
— "I'm jumping through hoops just to survive," exclaims one patient For over a year and a half, Tandra Cooper Harris and her husband, Marcus, both living with diabetes, have encountered countless difficulties in obtaining the medications necessary to manage their blood sugar levels. Without vital treatments like semaglutide (Ozempic) and other GLP-1 agonists, Cooper Harris experiences blackouts, lacks the energy to care for her grandchildren, and struggles to continue her job as
287 likes
10 659 views
